Ticagrelor Use in Indian Patients Undergoing Neuroendovascular Procedures: A Single Center Experience
Purpose A safe and efficacious antiplatelet drug is needed for patients with clopidogrel resistance who undergo neuroendovascular procedures. Ticagrelor is a new reversibly binding, oral, direct-acting P2Y receptor antagonist with no known resistance. We describe our clinical experience using ticagr...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Interventional Neuroradiology
2019-09-01
|
Series: | Neurointervention |
Subjects: | |
Online Access: | http://neurointervention.org/upload/pdf/neuroint-2019-00087.pdf |